Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2002-02-19 · DEPARTMENT OF HEALTH AND HUMAN SERVICES · Notices

Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

373 words·~2 min read·/register/2002/02/19/02-3832

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2, notice is hereby giving of a meeting of the Secretary's Advisory Committee on Xenotransplantation. The meeting will be open to the public; however, seating is limited and pre-registration is encouraged. To pre-register, please contact Capital Consulting Corporation (Joanne Mowczko) at 301-468-6001, ext. 418.
Individuals who plan to attend and need special assistance, such as sign language interpretation or reasonable accommodations, should notify Ms. Mowczko is advance of the meeting. *Name of Committee:* Secretary's Advisory Committee on Xenotransplantation. *Date:* March 11-12, 2002. *Time:* March 11—8:00 am to 5:00 PM. March 12—8:00 am to adjournment. *Agenda:* The SACX will focus on a variety of issues relating to the science of xenotransplantation and to informed consent issues in xenotransplantation clinical trials.
The first day of the SACX meeting will include presentations and discussions of endothelial cell-host interactions in solid organ xenotransplantation; transgenic and cloning technologies; cellular transplants; extracorporeal technologies; complement and coagulation systems; and immune rejection and tolerance. The second day will include concurrent breakout sessions during which the SACX Working Groups will convene, and plenary discussion of their progress. Closer to the meeting, a more updated agenda will be available electronically at *http://www4.od.nih.gov/oba/Sacx.htm* *Public Comment:* Individuals who wish to provide public comment (oral or written) should contact the SACX Executive Director, Mary Groesch, by telephone at 301-496-0785, or email at *groeschm@od.nih.gov.* *Place:* Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. *Contact Person:* Mary Groesch, Ph.D., Executive Director, Secretary's Advisory Committee on Xenotransplantation, Office of Science Policy, Rockledge, I, Room 750, Bethesda MD 20892, 301-496-9838 (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936 yNIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health HHS) Dated:
February 07, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02-3832 Filed 2-15-02; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.